Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 65

Sort by

Sort Order Select

Journal Articles

Prognostic Value of Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma

Lijuan Chen, MD PhD, Jianyong Li, MD

Blood (2019) 134 (Supplement_1): 1808.

https://doi.org/10.1182/blood-2019-123982

Published: 2019

Journal Articles

Type B Lactic Acidosis in Adults with Hemophagocytic Lymphohistiocytosis

Fares T. Rajah, MBBS, Abdullah S. S. Al Saleh, MBBS, Salih A. Bin Salih, MDFACP FRCP (Edin)

Blood (2019) 134 (Supplement_1): 4879.

https://doi.org/10.1182/blood-2019-121432

Published: 2019

Journal Articles

Clinical and Magnetic Resonance Imaging (MRI) Decision Making Rules in Differentiating Vaso-Occlusive Crises (VOCs) from Osteomyelitis in Paediatric Sickle Cell Population: Is MRI Pathognomonic?

Ahmed khalifa Al Shukaili, MD, Ahmed Abdullah Al Kharusi, MD, Eyad Tbaileh, MD, Hanan Nazir, Sameer Raniga, Alaa Al Manzalawy, Mohamed Ebrahim Mohamed Ebrahim Elshinawy, MD, Zaid Al Hinai, Laila Al Yazidi, Murtadha Al-Khabori, MD, Yasser Wali

Blood (2019) 134 (Supplement_1): 4824.

https://doi.org/10.1182/blood-2019-130861

Published: 2019

Journal Articles

Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease

Lu Zhang, Ai-lin Zhao, Ming-hui Duan, Zhi-yuan Li, Xin-xin Cao, Jun Feng, Dao-bin Zhou, Ding-rong Zhong, David C. Fajgenbaum, Jian Li

Blood (2019) 133 (16): 1720–1728.

https://doi.org/10.1182/blood-2018-11-884577

Published: 2019

Journal Articles

No Utility of Routine Laboratory Testing during Surveillance in Detecting Relapse in Patients with Classic Hodgkin Lymphoma in First Remission

Ryan C. Lynch, MD, Vandana Sundaram, MPH, Manisha Desai, PhD, Solomon Henry, MS, Douglas Wood, MS, Sarah Daadi, Karen S. Corbelli, Saul Rosenberg, MD, Richard T Hoppe, MD, Ranjana Advani, MD

Blood (2018) 132 (Supplement 1): 615.

https://doi.org/10.1182/blood-2018-99-113156

Published: 2018

Journal Articles

Urinary Cross-Linked Carboxyterminal Telopeptide Decreases with Resolution of Painful Vaso-Occlusive Crises in Adults with Sickle Cell Disease - Results from the Sickle Cell Pain Markers (SCPM) Study

Oyebimpe O. Adesina, MD, Isaac C. Jenkins, MS, Qian V. Wu, PhD, Ellen B. Fung, PhD RD, CCD, Kanika Mahajan, Rebecca Kruse-Jarres, MDMPH

Blood (2018) 132 (Supplement 1): 1100.

https://doi.org/10.1182/blood-2018-99-119801

Published: 2018

Journal Articles

Histiocytic Necrotizing Lymphadenitis, a Benign Mimic of Lymphoma Presenting with B Symptoms

Varsha Gupta, MD, Shreya Gor, MD, Anmol S Cheema, MD, Ravneet Bajwa, MD, Carrie Edelman, MD, Ethan Jeffrey Wasserman, MD

Blood (2018) 132 (Supplement 1): 4949.

https://doi.org/10.1182/blood-2018-99-118826

Published: 2018

Journal Articles

Erythrocyte Deformability As a Potential Biomarker for Chronic Fatigue Syndrome

Amit K Saha, Brendan R Schmidt, BS, Julie Wilhelmy, BA, Vy Nguyen, Justin Do, Vineeth C Suja, MS, Mohsen Nemat-Gorgani, PhD, Anand K Ramasubramanian, PhD, Ronald W Davis, PhD

Blood (2018) 132 (Supplement 1): 4874.

https://doi.org/10.1182/blood-2018-99-117260

Published: 2018

Journal Articles

Metabolic Tumor Volume and Soluble Cytokines Levels in Newly Diagnosed Hodgkin Lymphoma: What It Brings into the Staging Precision?

VIT K Prochazka, MD, Lenka Henzlova, MD, Marie Lukasova, MD, Veronika Hanackova, MD, Eva Kriegova, Dr, assoc prof, Zuzana Mikulkova, Dr, Gabriela Gabcova, Dr, Jiri Minarik, MD PhD, Alice Sýkorová, MD PhD, Eva Krcalova, MD, Jiri Dolezal, MD assoc prof, Pavel Koranda, MD assoc prof, Tomas Papajik, MD prof

Blood (2018) 132 (Supplement 1): 2933.

https://doi.org/10.1182/blood-2018-99-115150

Published: 2018

Journal Articles

Phenotype of Platelet Is Altered and Associated with Disease Activity of Rheumatoid Arthritis

Hidekata Yasuoka, MD PhD, Keiko Yoshimoto, PhD, Komei Sakata, MD, Mihoko Kato, Mako Koseki, Kotaro Matsumoto, MD, Hiroshi Takei, MD, Tsutomu Takeuchi, MD PhD

Blood (2017) 130 (Supplement 1): 3609.

https://doi.org/10.1182/blood.V130.Suppl_1.3609.3609

Published: 2017

Journal Articles

Comparison of Outcomes By Age of Patients with Limited Stage Hodgkin Lymphoma Treated with ABVD Alone; A Secondary Analysis of the Canadian Cancer Trial Group HD.6 Trial

Laura N Rodriguez-Romo, MD, Ralph Meyer, MDFRCPC, Joseph L Pater, MD, Jonathan Sussman, MD FRCPC, MSc, Siwei Zhang, MSc, Lui Hongbo, MSc, PhD, Jane N. Winter, MD, Te Vuong, MD, Walter Blahey, MD, Liam Mulroy, MD, Lois E. Shepherd, Marina S Djurfeldt, MSc, Bingshu E. Chen, Annette E Hay

Blood (2017) 130 (Supplement 1): 4081.

https://doi.org/10.1182/blood.V130.Suppl_1.4081.4081

Published: 2017

Journal Articles

Platelet Function Tests and Inflammatory Markers for the Differentiation of Primary Thrombocytosis and Secondary Thrombocytosis

Piyapong Kanya, MD, Ekarat Rattarittamrong, MD, Ornkamon Wongtagan, Thanawat Rattanathammethee, MD, Sasinee Hantrakool, MD, Chatree Chai-Adisaksopha, MD, Adisak Tantiworawit, MD, Lalita Norasetthada, MD

Blood (2017) 130 (Supplement 1): 4207.

https://doi.org/10.1182/blood.V130.Suppl_1.4207.4207

Published: 2017

Journal Articles

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

Blood (2017) 129 (12): 1646–1657.

https://doi.org/10.1182/blood-2016-10-746933

Published: 2017

Journal Articles

Thrombosis in Hodgkin Lymphoma Patients: Incidence, Time Points, Risk Factors and Impact of Stage and Treatment

Sven Borchmann, MD, Ida Hude, MD, Horst Müller, PhD, Heinz Haverkamp, Carolin Bürkle, MD, Michael Fuchs, MD, Peter Borchmann, MD, Andreas Engert, MD

Blood (2016) 128 (22): 4151.

https://doi.org/10.1182/blood.V128.22.4151.4151

Published: 2016

Journal Articles

The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma

Valentina Giudice, MD, Monia Rocco, PhD, Giancarlo Villani, Rosa Rosamilio, MD, Luca Pezzullo, MD, Bianca Serio, MD, Idalucia Ferrara, MD, Carmine Selleri, MD

Blood (2016) 128 (22): 1768.

https://doi.org/10.1182/blood.V128.22.1768.1768

Published: 2016

Journal Articles

Palliative Care of Multiple Myeloma Patients - a Nigerian Retrospective Outcome

Ogbonna Collins Nwabuko, MBBS (Ben), cpc (Kamp), FMCPath (Nig), Martins A. Nnoli, MBBS, FMCPath, Elizabeth Igbigbi, MBBCh, FMCPath

Blood (2016) 128 (22): 5678.

https://doi.org/10.1182/blood.V128.22.5678.5678

Published: 2016

Journal Articles

Prognostic Value of Baseline Quantitative PET Metrics for Patients with Unfavourable Early Stage Hodgkin Lymphoma Enrolled in the Standard Arm of the EORTC/Lysa/FIL H10 Trial

Blood (2016) 128 (22): 184.

https://doi.org/10.1182/blood.V128.22.184.184

Published: 2016

Journal Articles

Red Cell Distribution Width (RDW) at Diagnosis Is Associated to Advanced Stage, Worse Response and Poor Prognosis in Hodgkin Lymphoma

Bernardo Lopez Andrade, MD, Beatriz Robredo, MD, Francesca Sartori, MD, Inés Herráez, MD, Maria Antonia Duran Pastor, MD, Marta Garcia Recio, MD, Jorge Jose Martinez Serra, Leyre Bento, MD, Antonia Sampol, Jose Rodríguez, MD, Antonio Gutierrez, MD PhD

Blood (2016) 128 (22): 5373.

https://doi.org/10.1182/blood.V128.22.5373.5373

Published: 2016

Journal Articles

Malignancy Risk Markers in a Cohort of Referrals for Lymphadenopathy; An Evaluation of Clinical Features Including Lymph Node Size

Orlando Esparza, MD, Ana Xavier, MD, Matthew A. Kutny, MD, Julie A. Wolfson, MD, Jeffrey D. Lebensburger, DO MSPH

Blood (2016) 128 (22): 2385.

https://doi.org/10.1182/blood.V128.22.2385.2385

Published: 2016

Journal Articles

Clinical Significance of Soluble Interleukin-2 Receptor in Patients with Acute Leukemia

Dongjiao Wang, Jujuan Wang, MD, Hongxia Qiu, MD, PhD, Limin Duan, Tian Tian

Blood (2015) 126 (23): 4958.

https://doi.org/10.1182/blood.V126.23.4958.4958

Published: 2015

NARROW

Prognostic Value of Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma

Type B Lactic Acidosis in Adults with Hemophagocytic Lymphohistiocytosis

Clinical and Magnetic Resonance Imaging (MRI) Decision Making Rules in Differentiating Vaso-Occlusive Crises (VOCs) from Osteomyelitis in Paediatric Sickle Cell Population: Is MRI Pathognomonic?

Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease

No Utility of Routine Laboratory Testing during Surveillance in Detecting Relapse in Patients with Classic Hodgkin Lymphoma in First Remission

Urinary Cross-Linked Carboxyterminal Telopeptide Decreases with Resolution of Painful Vaso-Occlusive Crises in Adults with Sickle Cell Disease - Results from the Sickle Cell Pain Markers (SCPM) Study

Histiocytic Necrotizing Lymphadenitis, a Benign Mimic of Lymphoma Presenting with B Symptoms

Erythrocyte Deformability As a Potential Biomarker for Chronic Fatigue Syndrome

Metabolic Tumor Volume and Soluble Cytokines Levels in Newly Diagnosed Hodgkin Lymphoma: What It Brings into the Staging Precision?

Phenotype of Platelet Is Altered and Associated with Disease Activity of Rheumatoid Arthritis

Comparison of Outcomes By Age of Patients with Limited Stage Hodgkin Lymphoma Treated with ABVD Alone; A Secondary Analysis of the Canadian Cancer Trial Group HD.6 Trial

Platelet Function Tests and Inflammatory Markers for the Differentiation of Primary Thrombocytosis and Secondary Thrombocytosis

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

Thrombosis in Hodgkin Lymphoma Patients: Incidence, Time Points, Risk Factors and Impact of Stage and Treatment

The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma

Palliative Care of Multiple Myeloma Patients - a Nigerian Retrospective Outcome

Prognostic Value of Baseline Quantitative PET Metrics for Patients with Unfavourable Early Stage Hodgkin Lymphoma Enrolled in the Standard Arm of the EORTC/Lysa/FIL H10 Trial

Red Cell Distribution Width (RDW) at Diagnosis Is Associated to Advanced Stage, Worse Response and Poor Prognosis in Hodgkin Lymphoma

Malignancy Risk Markers in a Cohort of Referrals for Lymphadenopathy; An Evaluation of Clinical Features Including Lymph Node Size

Clinical Significance of Soluble Interleukin-2 Receptor in Patients with Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only